Dr.
GSK, Wavre, Belgium
Disclosure: GSK group of companies (Employee, Shareholder)
Fernanda Tavares holds a Medical Doctor degree, with Postgraduate in Gynecology and Obstetrics from the Central University of Venezuela and has had over 12 years of clinical practice. She has joined GlaxoSmithKline Biologicals in 2006, holding roles of increasing responsibility within Clinical Safety & Pharmacovigilance, driving global pharmacovigilance activities, particularly in relation to evaluation and interpretation of scientific and clinical safety data, signal detection, evaluation and risk management activities in particular for a variety of prophylactic and therapeutic Vaccines, as well as for the Adjuvant technology use in Vaccines. Fernanda is currently serving as Deputy EU-QPPV (Pharma, Vaccines and Consumer Health Medicines) and Head, Safety Evaluation & Risk Management of the Vaccines Research & Development Center based in Belgium. Over the past years, she has participated as active member of a variety of GSK vaccines Senior Governance and Advisory groups for safety-related topics and risk management strategies, in particular for Pregnancy Outcomes and Maternal Immunization.